National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
Department of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, Beijing, China.
BMC Public Health. 2019 Jul 8;19(1):901. doi: 10.1186/s12889-019-7061-1.
To determine the treatment behaviors among a community-based cohort of chronic hepatitis B virus (HBV)-infected persons and to examine the disease progression among non-antiviral-treated HBV-infected cases after 5 years of follow-up.
We conducted a community-based prospective study on people with chronic HBV infection in mainland China from 2009 to 2014. In 2009, we recruited participants who were identified as HBV infected in 2006 in a national sero-survey. A face-to-face follow-up investigation was completed in 2014, and the personal information, the clinical diagnosis provided at the last hospital visit, the HBV antiviral treatment history, and the insurance type was collected for each patient for analysis. Multivariable logistic regression was used to identify factors that are associated with active medical care- seeking and antiviral treatments.
Among the 2422 chronic HBV-infected patients recruited in 2009, 1784 (73.7%) were followed-up to 2014, and 638 (35.8%) had sought medical care in hospitals; among them, 140 (21.9%) received antiviral treatments. The lowest medical care-seeking rate (26%) was in participants over 50-year old. We determined that the frequency of medical care-seeking was higher among those participants living in urban areas (aRR = 1.3, 95% CI:1.0-1.6), those in 0-19-year old (aRR = 1.5, 95% CI:1.1-2.1), 20-39-year old (aRR = 2.2, 95% CI:1.7-3.0) and 40-49-year old (aRR = 1.5, 95% CI:1.1-2.0), and persons with insurance of the type Urban residents' basic medical insurance (URBMI) or Commercial health insurance (CHI) (aRR = 2.5, 95% CI:1.7-3.6) and New Rural Cooperative Medical System (NRCMS) (aRR = 1.9, 95% CI:1.4-2.6). Patients were more likely to receive antiviral treatment if they were 20-39-year old (aRR = 0.4, 95% CI:0.3-0.7), had insurance of the type URBMI or CHI (aRR = 2.6, 95% CI:1.1-6.3) or NRCMS (aRR = 3.0, 95% CI:1.3-6.9) and were treated at prefecture and above-level hospitals (aRR = 2.0, 95% CI:1.4-3.0). Among non-antiviral-treated HBV-infected cases, we found the annual rates for HBsAg sero-clearance, progress to cirrhosis and HCC were 1.0, 0.6 and 0.2%, respectively.
The rates of medical care-seeking and antiviral treatment were low among community-based chronic HBV-infected persons, thus we recommend improving the insurance policies for HBV-infected persons to increase the antiviral treatment rate, and conducting extensive education to promote HBV-infected patients actively seeking medical care from hospitals.
本研究旨在确定基于社区的慢性乙型肝炎病毒(HBV)感染者队列的治疗行为,并在随访 5 年后观察未接受抗病毒治疗的 HBV 感染者的疾病进展情况。
我们进行了一项基于中国大陆慢性 HBV 感染者的社区前瞻性研究。2009 年,我们招募了 2006 年全国血清学调查中确定的 HBV 感染者。2014 年完成了面对面随访调查,收集了每位患者的个人信息、最近一次就诊的临床诊断、HBV 抗病毒治疗史和保险类型,进行分析。多变量逻辑回归用于确定与积极寻求医疗护理和抗病毒治疗相关的因素。
在 2009 年招募的 2422 例慢性 HBV 感染者中,有 1784 例(73.7%)随访至 2014 年,其中 638 例(35.8%)在医院就诊;其中,140 例(21.9%)接受了抗病毒治疗。50 岁以上患者的医疗保健寻求率最低(26%)。我们发现,在城市地区居住的参与者(ARR=1.3,95%CI:1.0-1.6)、19 岁以下(ARR=1.5,95%CI:1.1-2.1)、20-39 岁(ARR=2.2,95%CI:1.7-3.0)和 40-49 岁(ARR=1.5,95%CI:1.1-2.0)以及具有城镇居民基本医疗保险(URBMI)或商业健康保险(CHI)(ARR=2.5,95%CI:1.7-3.6)和新型农村合作医疗(NRCMS)(ARR=1.9,95%CI:1.4-2.6)保险的患者寻求医疗护理的频率更高。20-39 岁(ARR=0.4,95%CI:0.3-0.7)、URBMI 或 CHI(ARR=2.6,95%CI:1.1-6.3)或 NRCMS(ARR=3.0,95%CI:1.3-6.9)保险以及在县级以上医院治疗的患者更有可能接受抗病毒治疗(ARR=2.0,95%CI:1.4-3.0)。在未接受抗病毒治疗的 HBV 感染者中,我们发现 HBsAg 血清学清除、进展为肝硬化和 HCC 的年发生率分别为 1.0%、0.6%和 0.2%。
基于社区的慢性 HBV 感染者寻求医疗护理和接受抗病毒治疗的比例较低,因此我们建议改善 HBV 感染者的保险政策,以提高抗病毒治疗率,并开展广泛的教育,促进 HBV 感染者积极寻求医院治疗。